The GOLD Podcast: Weekly Pharma Insights

Explore how the pharmaceutical industry can turn diversity, equality and inclusion initiatives into transformational change in the latest episode of the GOLD podcast, where Jade Williams talks to Anita Ralli, Director, Government Affairs, Inclusion and Diversity, Employee Resource Group Lead, Gilead Sciences UK.   

In this episode, Jade picks the brains of our guest to find out how companies can attract diverse talent to their workforce, key ways to create an environment where employees can be themselves and how to ensure Employee Resource Groups are successful. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  

Podcast: Pharma, Pride and the LGBTQ+ community

Podcast: International Women's Day 2023 special

My journey with diversity, equity and inclusion - Davidek Herron

4 top tips to create the perfect employee resource group

Last week's episode: Meet GOLD’s new catalyst – CSL Behring’s Karen Pinachyan

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Upgrading the personal touch in CX
• Crafting customer experience
• 5 ways pharma can ensure omnichannel success

In the penultimate episode of Season 4, the GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and experience within the pharmaceutical industry. Isabel and Zsuzsanna explore a wide range of topics during their conversation, including diversity and inclusion, the importance of climbing the ranks of leadership at the right pace, ensuring personalised medicines can reach patients in need and much more. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• Elevating pharma’s parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies 
• Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future 
• Driving access to all medicines: https://www.emg-gold.com/post/driving-access-to-all-medicines 
• Diversity: from ideas to action: https://www.emg-gold.com/post/diversity-from-ideas-to-action 

This week on the GOLD Podcast, Isabel and Jade present a conversation with Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, about how pharmaceutical teams can make the most of a tight budget and leverage digital transformation for the benefit of customers and patients.

During their discussion, Jade and Gaurav delve into his transition from retail to pharma, explore how companies can make quick wins by leveraging modular content and omnichannel and how AI is facilitating the digital transformation of marketing strategies.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  

• Upgrading the personal touch in CX https://www.emg-gold.com/post/upgrading-the-personal-touch-in-cx 
• AI, ChatGPT and modernising medical affairs https://www.emg-gold.com/post/ai-chatgpt-and-modernising-medical-affairs 
• Super reps, ChatGPT and pharma’s future on social media https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media 

This week on the GOLD podcast, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in the pharmaceutical industry and the potential uses of ChatGPT in medical affairs. In this episode, Matt explores the need to modernise medical affairs, top ways pharma teams could save time and resources with ChatGPT, the likelihood of AI one day becoming as commonplace as electricity and much more. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• Is medical affairs the Ferrari of the pharma industry?: https://www.emg-gold.com/post/podcast-is-medical-affairs-the-ferrari-of-the-pharma-industry 
• Medical affairs, AI and insight generation: https://www.emg-gold.com/post/medical-affairs-ai-and-insight-generation 
• Super reps, ChatGPT and pharma’s future on social media: https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media 
• Revealing the true value of medical affairs: https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs 

This week on the GOLD podcast, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation, to discuss all things access within the pharmaceutical industry. In this episode, Claudia and Jade explore a range of topics, including the story behind her passion for access to medicine, the industry's progress in making medicines more widely available in low- and middle-income countries and the Foundation's latest focus on driving access to generic drugs. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Claudia’s first GOLD Podcast: https://www.emg-gold.com/post/podcast-talking-to-claudia-martinez 

Pharma in Kenya: https://www.emg-gold.com/post/pharma-in-kenya

Pharma in India: https://www.emg-gold.com/post/pharma-in-india 

This week, the GOLD team is delighted to bring you a special International Women's Day (IWD) podcast featuring Pallavi Bansal, Associate Vice President of Oncology, Genitourinary Cancers and Haematology, Merck, and Emma Chaffin, Vice President, Country Head and Site Lead, Galapagos. The two women reflect on this year's IWD theme, #EmbracingEquity, why female representation in pharma is so important and how leaders can foster a sense of belonging within their organisations. Isabel and Jade also discuss the latest GOLD content on female representation and equality in pharma. 

Additional resources: 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• Infographic: Attracting more diverse talent into STEM https://www.emg-gold.com/_files/ugd/b8a9db_153874fc1b484455a9d2840f3118317c.pdf 
• Elevating pharma’s parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies 
• Reverse mentoring: a how-to guide: https://www.emg-gold.com/post/reverse-mentoring-a-how-to-guide 
• Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future 
• HBA Gender Parity Collaborative https://genderparity.hbanet.org/ 

This week, Isabel catches up with GOLD’s long-time friend Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS. She asks Bora to break down the value of the medical affairs function, asking whether it is being properly utilised by pharma organisations. Bora also shares his thoughts on the future of the MSL, what skills new recruits will need to succeed and his top predictions for the next five years in MA.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs
• Mastering medical affairs https://www.emg-gold.com/post/mastering-medical-affairs
• Darshan Kulkarni on Super reps, ChatGPT and pharma’s future on social media https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media

This week, GOLD talks to Darshan Kulkarni, Principal Attorney, The Kulkarni Law Firm, which focuses on regulatory and compliance for life sciences, about key trends in medical affairs and marketing today. He discusses whether MSLs will one day replace sales reps, the role of ChatGPT in healthcare, pharma’s future on social media and much more.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• The feature Darshan contributed to: Confronting health inequities for transgender patients https://www.emg-gold.com/post/confronting-health-inequities-for-transgender-patients
• A takeover, a tweet and trouble for pharma marketers https://www.emg-gold.com/post/a-takeover-a-tweet-trouble-for-pharma-marketers
• Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight
• Davidek Herron on 5 ways pharma can ensure omnichannel success https://www.emg-gold.com/post/5-ways-pharma-can-ensure-omnichannel-success-davidek-herron
• Mental health matters in pharma's approach to care https://www.emg-gold.com/post/mental-health-matters-in-pharma-s-approach-to-care

This week, the team shares a teaser of GOLD’s latest catalyst interview with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca. He talks to Isabel about why he decided to leave pharmacy for pharma, his passion for tackling unmet needs and championing the patient perspective as well as his thoughts on how to be an effective leader.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Catalyst interview: Mina Makar on tackling unmet patient needs https://www.emg-gold.com/post/mina-makar-on-tackling-unmet-patient-needs

Turning patient insights into action https://www.emg-gold.com/post/turning-patient-insights-into-action

Our last catalyst: John Wahba on the medical affairs evolution https://www.emg-gold.com/post/john-wahba-on-the-medical-affairs-evolution

The GOLD Podcast is back for Season 4, and it is returning with a bang as Helena speaks to Kavita Panke, Disease Area Strategy Leader, Neurodegeneration, Janssen. An inspiring pharma leader working in a rapidly evolving area of the industry, Kavita reveals the reasons behind her passion for neuroscience, how to build a high-performing team and her inspiring goals for 2023.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• The brains behind neurological breakthroughs
• The vast galaxy of neurology https://www.emg-gold.com/post/the-vast-galaxy-of-neurology
• The value of purpose https://www.emg-gold.com/post/the-value-of-purpose
• Claus Zieler on leadership https://www.emg-gold.com/post/claus-zieler-on-leadership

For our fourth and final GOLD Nugget of Season 3, Helena looks back to our Catalyst interview with Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology, sharing some of Reshema's ideas for tackling clinical trial recruitment gaps, her personal take on Nelson Mandela’s approach to dealing with failure and why she believes equal representation matters in the pharma industry and beyond.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Reshema’s full episode: Meet GOLD's next catalyst – Reshema Kemps-Polanco https://www.emg-gold.com/post/podcast-meet-gold-s-next-catalyst-visionary-leader-reshema-kemps-polanco
Catalyst interview: Reshema Kemps-Polanco on drive, diversity and finding time for family https://www.emg-gold.com/post/reshema-kemps-polanco-on-drive-diversity-and-finding-time-for-family
Ripples of change in R&D https://www.emg-gold.com/post/ripples-of-change-in-research-and-development
Setting the stage for a more equitable future https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future

Join Helena and Isabel in ringing in the new year with a special episode in which five of our previous guests share their predictions for what could lie ahead for the pharmaceutical industry in 2023. Together, they discuss a broad range of topics including greater implementation of digital health, social media’s impact on the space, new legislation and much more.

If you are interested in learning more about the topic areas discussed in this episode, check out the following content:

Looking forward to the future of pharma https://www.emg-gold.com/post/looking-forward-to-the-future-of-pharma-davidek-herron

Utilising data lakes in pharma https://www.emg-gold.com/post/utilising-data-lakes-in-pharma

Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs

The changing rhythm of digital therapeutics https://www.emg-gold.com/post/the-changing-rhythm-of-digital-therapeutics

Find a handy list of our guests’ full episodes at https://www.emg-gold.com/post/podcast-the-2023-pharma-forecast